Skip to Content


Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 30965


Food and Drug Administration, HHS.




The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Start Further Info


Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726,

End Further Info End Preamble Start Supplemental Information


The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

Table 1—List of Information Collections Approved By OMB

Title of collectionOMB control No.Date approval expires
National Panel of Tobacco Consumer Studies0910-08152/28/2023
Study of Oncology Indications in Direct-to-Consumer Television Advertising0910-08852/28/2023
Premarket Approval of Medical Devices0910-02313/31/2023
Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing of Juice0910-04663/31/2023
Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions0910-02334/30/2023
Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products0910-06754/30/2023
Testing Communications on Medical Devices and Radiation-Emitting Products0910-06784/30/2023
Requests for Nonbinding Feedback After Certain FDA Inspections of Device Establishments0910-08864/30/2023
Start Signature

Dated: May 18, 2020.

Lowell J. Schiller,

Principal Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2020-10977 Filed 5-20-20; 8:45 am]